Enhanced circulating soluble LR11 in patients with coronary organic stenosis

被引:33
|
作者
Takahashi, Mao [1 ]
Bujo, Hideaki [2 ]
Jiang, Meizi [2 ]
Noike, Hirofumi [1 ]
Saito, Yasushi [3 ]
Shirai, Kohji [4 ]
机构
[1] Toho Univ, Sakura Hosp, Med Ctr, Dept Cardiovasc Ctr, Chiba 2748510, Japan
[2] Chiba Univ, Grad Sch Med, Dept Genome Res & Clin Applicat, Chiba, Japan
[3] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol, Chiba, Japan
[4] Toho Univ, Sakura Hosp, Med Ctr, Dept Internal Med, Sakura 2858741, Japan
关键词
LR11; Coronary stenosis; Hyperglycemia; Intimal smooth muscle cell; SMOOTH-MUSCLE-CELLS; INTIMAL-MEDIAL THICKNESS; RECEPTOR FAMILY-MEMBER; INSULIN-RESISTANCE; MIGRATION; EXPRESSION; ATHEROSCLEROSIS; OVEREXPRESSION; DISEASE;
D O I
10.1016/j.atherosclerosis.2009.12.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
LR11, an LDL receptor family member, is expressed in intimal smooth muscle cells. It was found that the soluble form of LR11 (sLR11) is detected in serum, and the circulating sLR11 levels are positively correlated with intima-media thickness of carotid arteries in dyslipidemic subjects. To clarify the significance of serum sLR11, the circulating sLR11 levels in patients with organic coronary stenosis and the contributing risk factors for them were studied. The subjects, 150 patients with symptoms of coronary artery disease, underwent coronary angiographic examination, and were divided into sex-and age-matched two groups; one is organic coronary stenosis group (OCS) and the other is normal coronary group (NC). Serum sLR11 levels were significantly higher in OCS than in NC (4.9 +/- 2.7 U vs 3.6 +/- 1.8 U, p < 0.05). Multivariate regression analysis showed that circulating sLR11 is independent contributing factor for the OCS, as well as diabetes mellitus and dyslipidemia. Among various coronary risk factors for sLR11 level, HbA1c showed the highest correlation coefficient (p < 0.01). These results suggest that the circulating sLR11 might reflect coronary organic stenosis, and that hyperglycemic condition might be promoting factor for expression of LR11 in intimal smooth muscle cells. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:581 / 584
页数:4
相关论文
共 50 条
  • [1] Enhanced Circulating Soluble LR11 in Patients With Diabetic Retinopathy
    Takahashi, Mao
    Bujo, Hideaki
    Shiba, Tomoaki
    Jiang, Meizi
    Maeno, Takatoshi
    Shirai, Kohji
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 154 (01) : 187 - 192
  • [2] Increased circulating soluble LR11 in patients with acute coronary syndrome
    Ogita, Manabu
    Miyauchi, Katsumi
    Dohi, Tomotaka
    Tsuboi, Shuta
    Miyazaki, Tadashi
    Yokoyama, Takayuki
    Yokoyama, Ken
    Shimada, Kazunori
    Kurata, Takeshi
    Jiang, Meizi
    Bujo, Hideaki
    Daida, Hiroyuki
    CLINICA CHIMICA ACTA, 2013, 415 : 191 - 194
  • [3] Circulating levels of soluble form of LR11, a novel migration regulator of intimal SMC, are increased in subjects with coronary stenosis
    Takahashi, Mao
    Bujo, Hideaki
    Jiang, Meiji
    Ohwaki, Kenji
    Noike, Hirofumi
    Schneider, Wolfagang J.
    Salto, Yasushi
    Shirai, Kohji
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A296 - A296
  • [4] Development of an Immunoassay for the Quantification of Soluble LR11, a Circulating Marker of Atherosclerosis
    Matsuo, Masanao
    Ebinuma, Hiroyuki
    Fukamachi, Isamu
    Jiang, Meizi
    Bujo, Hideaki
    Saito, Yasushi
    CLINICAL CHEMISTRY, 2009, 55 (10) : 1801 - 1808
  • [5] Prognostic impact of circulating soluble LR11 on long-term clinical outcomes in patients with coronary artery disease
    Ogita, Manabu
    Miyauchi, Katsumi
    Kasai, Takatoshi
    Tsuboi, Shuta
    Wada, Hideki
    Naito, Ryo
    Konishi, Hirokazu
    Dohi, Tomotaka
    Tamura, Hiroshi
    Okazaki, Shinya
    Yanagisawa, Naotake
    Shimada, Kazunori
    Suwa, Satoru
    Jiang, Meizi
    Bujo, Hideaki
    Daida, Hiroyuki
    ATHEROSCLEROSIS, 2016, 244 : 216 - 221
  • [6] ENHANCED CIRCULATING SOLUBLE LR11 AFTER CORONARY STENTING, A NOVEL MARKER OF SMOOTH MUSCLE CELL MIGRATION IN RESPONSE TO VASCULAR INJURY
    Ogita, Manabu
    Miyauchi, Katsumi
    Jiang, Meizi
    Tsuboi, Shuta
    Naito, Ryo
    Konishi, Hirokazu
    Dohi, Tomotaka
    Kasai, Takatoshi
    Bujo, Hideaki
    Daida, Hiroyuki
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1138 - E1138
  • [7] Circulating soluble LR11, a novel marker of smooth muscle cell proliferation, is enhanced after coronary stenting in response to vascular injury
    Ogita, Manabu
    Miyauchi, Katsumi
    Jiang, Meizi
    Kasai, Takatoshi
    Tsuboi, Shuta
    Naito, Ryo
    Konishi, Hirokazu
    Dohi, Tomotaka
    Yokoyama, Takayuki
    Okazaki, Shinya
    Shimada, Kazunori
    Bujo, Hideaki
    Daida, Hiroyuki
    ATHEROSCLEROSIS, 2014, 237 (01) : 374 - 378
  • [8] Levels of circulating soluble LR11, a regulator of smooth muscle cell migration, are highly associated with atherosclerotic plaques in patients with carotid artery stenosis
    Harada, Masashi
    Jiang, Meizi
    Terai, Kensuke
    Ebinuma, Hiroyuki
    Hiruta, Nobuyuki
    Schneider, Wolfgang J.
    Sugo, Nobuo
    Nagao, Takeki
    Bujo, Hideaki
    CLINICA CHIMICA ACTA, 2019, 490 : 69 - 76
  • [9] Impact of Soluble LR11 on Target Lesion Revascularization After Coronary Intervention in Patients with Stable Coronary Artery Disease
    Ogita, Manabu
    Miyauchi, Katsumi
    Dohi, Tomotaka
    Miyazaki, Tadashi
    Nakajima, Naohisa
    Yokoyama, Takayuki
    Kojima, Takahiko
    Yokoyama, Ken
    Kurata, Takeshi
    Bujyo, Hideaki
    Daida, Hiroyuki
    CIRCULATION, 2010, 122 (21)
  • [10] Circulating soluble LR11/SorLA levels are highly increased and ameliorated by chemotherapy in acute leukemias
    Sakai, Shio
    Nakaseko, Chiaki
    Takeuchi, Masahiro
    Ohwada, Chikako
    Shimizu, Naomi
    Tsukamoto, Shokichi
    Kawaguchi, Takeharu
    Jiang, Meizi
    Sato, Yasunori
    Ebinuma, Hiroyuki
    Yokote, Koutaro
    Iwama, Atsushi
    Fukamachi, Isamu
    Schneider, Wolfgang Johann
    Saito, Yasushi
    Bujo, Hideaki
    CLINICA CHIMICA ACTA, 2012, 413 (19-20) : 1542 - 1548